At SOHO 2025, Lorenzo Falchi, MD, highlighted the critical role of nurses in monitoring and educating patients on toxicities ...

Michelle Kirschner, MSN, RN, ACNP, APRN-BC, discusses how precision supportive care tailors interventions to patient needs.

Formerly known as TAR-200, gemcitabine intravesical system has received the FDA’s approval for use in patients with ...

New AQUILA data show PFS improvement in patients with smoldering multiple myeloma who were treated with subcutaneous ...

Expert Kelsey Martin shares nursing insights on balancing glucose control and GI side effects when caring for patients on ...

Biology-guided radiotherapy involves teamwork across multiple specialists, according to Samantha Bianzon, BSN, RN.

Familiarity with each component of antibody-drug conjugates helps nurses and APPs deliver proactive adverse event management ...

Tepotinib was associated with frequent but manageable adverse events in MET exon 14–positive NSCLC, with peripheral edema ...

The NDA’s acceptance is based on positive data from the phase 3 ROSELLA trial (NCT05257408) as well as from a previous phase ...

Lisa Hwa Christenson, DNP, CNP, FAPO, shares best practices for monitoring CRS and ICANS with BCMA bispecific antibodies in ...

Oncology Nursing News connects oncology nurses and APPs with updates on therapy advances, side effect management, and patient ...

Other AEs linked to menin inhibitors include cytopenias and mild gastrointestinal symptoms, such as nausea. Still, Issa noted that compared with many other AML therapies, these agents generally ...